What about Shandong Kexing Biological Products Co., Ltd.?

Introduction: Shandong Kexing Biological Products Co., Ltd. is a biopharmaceutical high-tech enterprise jointly funded by Zhongzheng Pharmaceutical Group Co., Ltd. and Shenzhen Kexing Biological Engineering Co., Ltd., which is mainly responsible for the research and development, industrialization and commercial operation of genetic engineering drugs and microecological drugs. Shandong Kexing Biological Products Co., Ltd. was established in 1997, located in Mingshui Development Zone, Zhangqiu City, Shandong Province, and now has a garden-style factory building.

Recombinant human erythropoietin injection (CHO cells) (rhEPO), with the trade name of "iprodione", is a genetic engineering drug and a national second-class new drug. Its research and development process was included in the national torch plan, and was also included in the top ten high-tech projects in Shandong Province, and won the first prize of medical science and technology progress in Shandong Province. 1996 China was the first country to obtain a new drug certificate, and 1997 was the first country to put its products on the market, which filled the domestic gap and marked that China became the fourth successful country in the world after the United States, Japan and Germany, ending the occupation and monopoly of China market by foreign products.

Our company's recombinant human granulocyte stimulating factor injection (rhG-CSF), with the trade name of "Baxi", is a national second-class new drug. It is another genetic engineering drug successfully developed and produced by the company after the listing of 200 1 iprodine.

Clostridium butyricum combined with live bacteria powder capsule is a new microecological preparation with the trade name of "Changle Kang", which is a kind of new drug listed in the national new drug development fund plan, and has independent intellectual property rights. The invention patent number is 97115093.1.

Legal Representative: Deng Xueqin

Date of establishment: 1997-08-22

Registered capital: 65,438+049,025, 350 yuan.

Location: Shandong Province

Unified social credit code: 9137018161324 3451m.

Business status: in-service (opened) enterprises.

Industry: manufacturing industry

Company type: other limited liability companies

English name: Shandong Kexing Biological Products Co., Ltd.

Number of employees: 100-499.

Enterprise address: No.2666 Chuangye Road, Mingshui Development Zone, Zhangqiu District, Jinan City, Shandong Province (No.2666 Chuangye Road, Mingshui Development Zone, Erdiao Town, east of Shengquan East Road)

Business scope: R&D, production and sales of bioengineered products (recombinant human erythropoietin injection (CHO cells) and recombinant human granulocyte stimulating factor injection), immune preparations (Clostridium butyricum capsules and Clostridium butyricum powder), raw materials and preparations; Technical research and development, technical consultation and technology transfer services for biological products; Import and export of goods and technologies; Lease of self-owned houses that are not prohibited by laws, regulations and the State Council decisions and do not require business licenses. (Projects subject to approval according to law can only be operated after approval by relevant departments). (Projects subject to approval according to law can only be operated after approval by relevant departments)